| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |